Delivery of exogenous miR-19b by Wharton’s Jelly Mesenchymal Stem Cells attenuates transplanted kidney ischemia/reperfusion injury by regulating cellular metabolism-Reference-Cited by-同舟云学术

Delivery of exogenous miR-19b by Wharton’s Jelly Mesenchymal Stem Cells attenuates transplanted kidney ischemia/reperfusion injury by regulating cellular metabolism

Published:2024-06-25 Issue: Volume: Page:
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Wu Xiaoqiang,Wu Xuan,Wang Zhiwei,Tian Xiangyong,Zhang Chan,Cao Guanghui,Gu Yue,Yan Tianzhong

Funder

Key Scientific Research Projects in Universities of Henan Province

Henan Province Medical Science and Technology Research Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13346-024-01645-3.pdf

Reference41 articles.

1. Ibi Y, Nishinakamura R. Kidney bioengineering for transplantation. Transplantation. 2023;107(9):1883–94. https://doi.org/10.1097/tp.0000000000004526.

2. van Duijl TT, de Rooij ENM, Treep MM, Koelemaij ME, Romijn F, Hoogeveen EK, et al. Urinary kidney injury biomarkers are associated with ischemia-reperfusion injury severity in kidney allograft recipients. Clin Chem. 2023;69(8):924–35. https://doi.org/10.1093/clinchem/hvad086.

3. Bahl D, Haddad Z, Datoo A, Qazi YA. Delayed graft function in kidney transplantation. Curr Opin Organ Transpl. 2019;24(1):82–6. https://doi.org/10.1097/mot.0000000000000604.

4. Wang Y, Fang J, Liu B, Shao C, Shi Y. Reciprocal regulation of mesenchymal stem cells and immune responses. Cell Stem Cell. 2022;29(11):1515–30. https://doi.org/10.1016/j.stem.2022.10.001.

5. Liau LL, Ruszymah BHI, Ng MH, Law JX. Characteristics and clinical applications of Wharton’s jelly-derived mesenchymal stromal cells. Curr Res Transl Med. 2020;68(1):5–16. https://doi.org/10.1016/j.retram.2019.09.001.